These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 17890877)
1. Effect of iron loading on peripheral blood lymphocyte subsets and on circulating cytokine levels in iron-depleted hemodialysis patients receiving erythropoietin. Tsouchnikas I; Tsilipakou M; Daniilidis M; Kyriazis G; Pasadakis P; Parapanissiou E; Vargemezis V; Tsakiris D Nephron Clin Pract; 2007; 107(3):c97-102. PubMed ID: 17890877 [TBL] [Abstract][Full Text] [Related]
2. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia. Attallah N; Osman-Malik Y; Frinak S; Besarab A Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942 [TBL] [Abstract][Full Text] [Related]
3. Recombinant human erythropoietin resistance in hemodialysis. Effects of paired filtration dialysis. Carozzi S; Nasini MG; Santoni O; Tirotta A; Sanna A ASAIO J; 1997; 43(5):M535-8. PubMed ID: 9360100 [TBL] [Abstract][Full Text] [Related]
4. Intravenous ascorbic acid in hemodialysis patients with functional iron deficiency: a clinical trial. Giancaspro V; Nuzziello M; Pallotta G; Sacchetti A; Petrarulo F J Nephrol; 2000; 13(6):444-9. PubMed ID: 11132761 [TBL] [Abstract][Full Text] [Related]
5. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia. Li H; Wang SX Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498 [TBL] [Abstract][Full Text] [Related]
6. Inflammatory, degenerative and vascular lesions in long-term dialysed patients. Vrabie CD; Petrescu A; Waller M; Cojocaru M; Ciocâlteu A; Dina I Rom J Intern Med; 2009; 47(2):149-59. PubMed ID: 20067165 [TBL] [Abstract][Full Text] [Related]
7. Erythropoietin requirements: a comparative multicenter study between peritoneal dialysis and hemodialysis. Coronel F; Herrero JA; Montenegro J; Fernandez C; Gandara A; Conesa J; Rivera MT; Torrente J; Portolés J; Gomez-Martino JR J Nephrol; 2003; 16(5):697-702. PubMed ID: 14733416 [TBL] [Abstract][Full Text] [Related]
8. [Influence of erythropoietin on immunological system of patients with chronic renal failure]. Debska-Slizień A; Rutkowski B; Manitius J; Zdrojewski Z; Szołkiewicz M; Bułło B; Lizakowski S; Myśliwska J; Myśliwski A; Bryl E; Trzonkowski P; Bakowska A; Rachoń D Pol Merkur Lekarski; 2003 Oct; 15(88):326-7; discussion 327-9. PubMed ID: 14974359 [TBL] [Abstract][Full Text] [Related]
9. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients. Chen YC; Hung SC; Tarng DC Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299 [TBL] [Abstract][Full Text] [Related]
10. The effects of intravenous iron treatment on oxidant stress and erythrocyte deformability in hemodialysis patients. Cavdar C; Temiz A; Yeniçerioğlu Y; Calişkan S; Celik A; Sifil A; Onvural B; Camsari T Scand J Urol Nephrol; 2003; 37(1):77-82. PubMed ID: 12745750 [TBL] [Abstract][Full Text] [Related]
11. Lymphocyte 5'-nucleotidase and aminopeptidase N activity in patients on maintenance hemodialysis treated with human recombinant erythropoietin and 1-alpha-D3. Stefanovic V; Mitić-Zlatkovic M; Radivojevic J; Vlahovic P Ren Fail; 2005; 27(3):283-8. PubMed ID: 15957544 [TBL] [Abstract][Full Text] [Related]
12. Comparative response to single or divided doses of parenteral iron for functional iron deficiency in hemodialysis patients receiving erythropoietin (EPO). Saltissi D; Sauvage D; Westhuyzen J Clin Nephrol; 1998 Jan; 49(1):45-8. PubMed ID: 9491286 [TBL] [Abstract][Full Text] [Related]
13. Importance of iron supply for erythropoietin therapy. Sunder-Plassmann G; Hörl WH Nephrol Dial Transplant; 1995 Nov; 10(11):2070-6. PubMed ID: 8643170 [TBL] [Abstract][Full Text] [Related]
14. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period. Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241 [TBL] [Abstract][Full Text] [Related]
15. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry. Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277 [TBL] [Abstract][Full Text] [Related]
16. Effect of repeated intravenous iron administration in haemodialysis patients on serum 8-hydroxy-2'-deoxyguanosine levels. Maruyama Y; Nakayama M; Yoshimura K; Nakano H; Yamamoto H; Yokoyama K; Lindholm B Nephrol Dial Transplant; 2007 May; 22(5):1407-12. PubMed ID: 17264097 [TBL] [Abstract][Full Text] [Related]
17. Soluble transferrin receptor is correlated with erythropoietin sensitivity in dialysis patients. Daschner M; Mehls O; Schaefer F Clin Nephrol; 1999 Oct; 52(4):246-52. PubMed ID: 10543327 [TBL] [Abstract][Full Text] [Related]
18. Lymphocyte subsets in dialyser eluates: a new parameter of bioincompatibility? Grooteman MP; Nube MJ; van Limbeek J; Schoorl M; van Houte AJ Nephrol Dial Transplant; 1996 Jun; 11(6):1073-8. PubMed ID: 8671971 [TBL] [Abstract][Full Text] [Related]
19. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix. Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133 [TBL] [Abstract][Full Text] [Related]
20. Acute effect of hemodialysis on serum levels of the proinflammatory cytokines. Tarakçioğlu M; Erbağci AB; Usalan C; Deveci R; Kocabaş R Mediators Inflamm; 2003 Feb; 12(1):15-9. PubMed ID: 12745544 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]